Research feed

Latest Diabetes Research

Recently added diabetes research, organized by intervention and outcome.

Sorted by when Dediabetes added each study.

Last updated: Sep 9, 20261,200 studies indexed

July 2026

Added to Dediabetes Jul 12, 2026RCTs

Exercise Improves Sleep Habits in Children with Type 1 Diabetes

This study investigated the impact of a regular exercise program on sleep habits in children with Type 1 Diabetes, revealing significant improvements in various sleep-related outcomes.

Interventions
Aerobic exercise
Outcomes
Average sleep habits score measured by the Children's Sleep Habits QuestionnaireBedtime resistanceNight wakings score+6 more
Added to Dediabetes Jul 12, 2026RCTs

Family-DSMES improves diabetes outcomes in diverse adults

This study compared Family-DSMES and Standard-DSMES in participants with diabetes, finding significant improvements in diabetes-related family involvement with Family-DSMES.

Interventions
DSMES
Outcomes
HbA1cImprovement in diabetes-related helpful family involvement
Added to Dediabetes Jul 12, 2026RCTs

Finerenone improves heart failure outcomes in patients with diabetes.

The Finerenone Trial investigated the efficacy and safety of finerenone compared to placebo in patients with heart failure, demonstrating significant benefits.

Interventions
Finerenone (nonsteroidal mineralocorticoid receptor antagonist)
Outcomes
Cardiovascular deathHospitalization for heart failureTotal worsening heart failure events and death from cardiovascular causes
Added to Dediabetes Jul 12, 2026RCTs

Finerenone improves kidney outcomes in Chinese patients with type 2 diabetes.

The FIGARO-DKD trial subgroup analysis evaluated finerenone in patients with type 2 diabetes and chronic kidney disease, finding significant reductions in kidney failure risk.

Interventions
Finerenone (nonsteroidal mineralocorticoid receptor antagonist)
Outcomes
Incidence of hyperkalemiaTime to cardiovascular deathTime to kidney failure, sustained eGFR decline ≥40% from baseline, or kidney-related death
Added to Dediabetes Jul 12, 2026RCTs

Finerenone reduces heart and kidney event risk in CKD and T2D

This study evaluated the effects of finerenone on heart and kidney events in patients with chronic kidney disease and type 2 diabetes, finding significant reductions in event rates compared to placebo.

Interventions
Finerenone (nonsteroidal mineralocorticoid receptor antagonist)
Outcomes
Adverse events incidenceComposite cardiovascular events (CV death, MI, stroke, HF hospitalization)Composite cardiovascular outcome+4 more
Added to Dediabetes Jul 12, 2026RCTs

Finerenone reduces hypokalaemia risk in CKD and T2D patients.

The study evaluated the effect of Finerenone on hypokalaemia in patients with chronic kidney disease and type 2 diabetes, finding a significant reduction in incidence compared to placebo.

Interventions
Finerenone (nonsteroidal mineralocorticoid receptor antagonist)
Outcomes
Arrhythmia composite outcomeComposite cardiovascular events (CV death, MI, stroke, HF hospitalization)Hypokalaemia incidence

Latest Evidence

Never miss new evidence

Build your workspace to keep track of the latest diabetes research.